SOLV
Solventum · Health Care
4.2%
typical move (median |reaction| of last 8)
2026-11-05 post
next expected · estimated from IR page
10
scored events
Last eight reactions
2024-11-07 → 2026-08-05
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-08-05 | post | -5.0% | 5.0% | +3.0% | +10.7% |
| 2026-05-05 | post | +2.8% | 2.8% | +3.7% | +13.0% |
| 2026-02-26 | post | -3.5% | 3.5% | -4.5% | -8.1% |
| 2025-11-06 | post | +8.0% | 8.0% | +5.6% | +13.5% |
| 2025-08-07 | post | +1.9% | 1.9% | -3.6% | +0.0% |
| 2025-05-08 | post | +5.7% | 5.7% | +0.1% | +0.4% |
| 2025-02-27 | post | -4.4% | 4.4% | +0.7% | -0.1% |
| 2024-11-07 | post | -3.9% | 3.9% | -4.7% | -3.6% |
Source filings
2026-08-05 · 8-K press release
Solventum Reports Second Quarter 2026 Financial Results • R eported sales increased 2.2%; organic sales increased 9.5% • Announces intent to separate its Health Information Systems business segment •
2026-05-05 · 8-K press release
Solventum Reports First Quarter 2026 Financial Results • R eported sales decreased (3.0)%; organic sales increased 2.1% • Affirms full-year 2026 organic sales growth and free cash flow guidance; estim
2026-02-26 · 8-K press release
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance • R eported sales decreased 3.7%; organic sales increased 3.5% • Introduces full-year 2026 organic sales
2025-11-06 · 8-K press release
Solventum Reports Third Quarter 2025 Financial Results • R eported sales increased 0.7%; organic sales increased 2.7% • Expects full year organic sales growth to be at the high end of +2.0% to +3.0% r
2025-08-07 · 8-K press release
Solventum Reports Second Quarter 2025 Financial Results • Reported sales increased 3.9%; organic sales increased 2.8% • Increases full year organic sales growth outlook to +2.0% to +3.0% • Increases f
2025-05-08 · 8-K press release
Solventum Reports First Quarter 2025 Financial Results • Reported sales increased 2.6%; organic sales increased 4.3% • Increases full year organic sales growth outlook by 50 bps to +1.5% to +2.5% ST.
2025-02-27 · 8-K press release
Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance • Reported sales increased 1.9% to $2.074 billion; organic sales increased 2.3% • GAAP diluted Earnings P
2024-11-07 · 8-K press release
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance • Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% • GAAP Earnings Per Share (EPS) of